Valiant Laborato

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE0JWS01017
NSEID: VALIANTLAB
BSEID: 543998
View on NSE | View on BSE

INR

67.90

-0.83 (-1.21%)

BSENSE

Jun 19, 03:30 PM

BSE+NSE Vol: 7.43 k

{
  "main_header": {
    "sid": 10039033,
    "name": "Valiant Laborato",
    "stock_name": "Valiant Laborato",
    "full_name": "Valiant Laboratories Ltd",
    "name_url": "stocks-analysis/valiant-laborato",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "67.90",
    "chg": -0.83,
    "chgp": "-1.21%",
    "dir": -1,
    "prev_price": "68.73",
    "mcapval": "375.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 543998,
    "symbol": "VALIANTLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE0JWS01017",
    "curr_date": "Jun 19, 03:30 PM",
    "curr_time": "04:34 AM",
    "last_traded_at": "Jun 19, 03:30 PM IST",
    "bse_nse_vol": "7.43 k",
    "exc_status": "Active",
    "traded_date": "Jun 19, 2026",
    "traded_date_str": "2026 06 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/valiant-laborato-10039033-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Below All Moving Averages and Now at Lower Circuit: Valiant Laboratories Ltd Loses 5.0% in a Single Session",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-laboratories-ltd-hits-lower-circuit-amid-heavy-selling-pressure-4054528",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ValiantLaborato_stocks_hitting_lower_circuit_4054528.png",
        "date": "2026-06-15 14:00:11",
        "description": "At Rs 64.60, sellers were still queuing — but there were no buyers willing to take the other side. Valiant Laboratories Ltd locked at its lower circuit of 5.0% on 15 Jun 2026, with unfilled sell orders and a frozen price, signalling persistent selling pressure in a micro-cap stock with limited liquidity."
      },
      {
        "title": "Valiant Laboratories Ltd Falls 5.46%: 2 Key Technical Events Shape the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-laboratories-ltd-falls-546-2-key-technical-events-shape-the-week-4050710",
        "imagepath": "",
        "date": "2026-06-13 09:07:33",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>8 Jun:</strong> Stock opens at Rs.74.79, gains 1.30% despite Sensex decline</p>\n                    <p><strong>9 Jun:</strong> Sharp drop of 3.92% amid sector divergence</p>\n                    <p><strong>10 Jun:</strong> Hits lower circuit at Rs.69.18 amid heavy selling pressure</p>\n                    <p><strong>11 Jun:</strong> Continues decline, closing at Rs.67.18 (-4.03%)</p>\n                    <p><strong>12 Jun:</strong> Rebounds 3.90% with Golden Cross technical signal</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.73.83</div></div>\n           ..."
      },
      {
        "title": "Golden Cross Forms in Valiant Laboratories Ltd — Mixed Technical Signals and Micro-Cap Caveats",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-laboratories-ltd-forms-golden-cross-signalling-potential-bullish-breakout-4049383",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ValiantLaborato_goldencross_4049383.png",
        "date": "2026-06-12 18:10:58",
        "description": "The 50-day moving average has crossed above the 200-day for Valiant Laboratories Ltd, signalling a golden cross on 12 Jun 2026. Yet, the broader technical picture is conflicted, with weekly and monthly indicators sending mixed messages, and the stock’s micro-cap status adding a layer of caution to interpreting this signal."
      },
      {
        "title": "Valiant Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/valiant-laboratories-ltd-is-rated-sell-4048786",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ValiantLaborato_mojoScore_4048786.png",
        "date": "2026-06-12 10:10:57",
        "description": "Valiant Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 8 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 June 2026, providing investors with the most up-to-date insight into the company’s performance and outlook."
      },
      {
        "title": "Valiant Laboratories Ltd Locks at Lower Circuit With 4.88% Loss — Sellers Queue, No Buyers in Sight",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-laboratories-ltd-hits-lower-circuit-amid-heavy-selling-pressure-4044207",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ValiantLaborato_stocks_hitting_lower_circuit_4044207.png",
        "date": "2026-06-10 12:00:11",
        "description": "At Rs 69.27, Valiant Laboratories Ltd found itself locked at its lower circuit limit of 5% on 10 Jun 2026, with persistent selling pressure overwhelming demand and leaving unfilled supply on the exchange floor."
      },
      {
        "title": "Valiant Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/valiant-laboratories-ltd-is-rated-sell-4025953",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ValiantLaborato_mojoScore_4025953.png",
        "date": "2026-06-01 10:10:51",
        "description": "Valiant Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Valiant Laboratories Ltd Falls 0.75%: 3 Key Factors Driving the Week’s Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-laboratories-ltd-falls-075-3-key-factors-driving-the-weeks-volatility-4008024",
        "imagepath": "",
        "date": "2026-05-23 11:01:01",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>18 May:</strong> Quality grade upgrade signals mixed fundamentals</p>\n                    <p><strong>19 May:</strong> Valuation shifts indicate heightened price risk</p>\n                    <p><strong>21 May:</strong> Downgrade to Strong Sell amid mixed financial and technical signals</p>\n                    <p><strong>22 May:</strong> Week closes at Rs.78.19 (-0.75%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.78.78</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.78.19</div><d..."
      },
      {
        "title": "Valiant Laboratories Downgraded to Strong Sell Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/valiant-laboratories-downgraded-to-strong-sell-amid-mixed-financial-and-technical-signals-4002334",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ValiantLaborato_mojoScore_4002334.png",
        "date": "2026-05-21 08:28:13",
        "description": "Valiant Laboratories Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 20 May 2026, reflecting a complex interplay of improved quarterly financials but deteriorating quality and valuation metrics, alongside mixed technical indicators. Despite a positive financial trend in the latest quarter, concerns over long-term fundamentals and expensive valuation have weighed heavily on investor sentiment."
      },
      {
        "title": "Valiant Laboratories Ltd Valuation Shifts Signal Heightened Price Risk",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-laboratories-ltd-valuation-shifts-signal-heightened-price-risk-3997935",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ValiantLaborato_valuationdot_3997935.png",
        "date": "2026-05-19 08:02:54",
        "description": "Valiant Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation metrics shift markedly, moving from an already expensive rating to very expensive territory. Despite a recent downgrade in its Mojo Grade from Strong Sell to Sell, the stock has delivered mixed returns compared to the broader Sensex, prompting investors to reassess its price attractiveness amid challenging fundamentals and peer comparisons."
      }
    ],
    "total": 320,
    "sid": "10039033",
    "stock_news_url": "https://www.marketsmojo.com/news/valiant-laboratories-10039033"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Valiant Laboratories Ltd has announced <strong>1:4</strong> rights issue, ex-date: 18 Jul 25",
          "dt": "2025-07-18",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Below All Moving Averages and Now at Lower Circuit: Valiant Laboratories Ltd Loses 5.0% in a Single Session

2026-06-15 14:00:11

At Rs 64.60, sellers were still queuing — but there were no buyers willing to take the other side. Valiant Laboratories Ltd locked at its lower circuit of 5.0% on 15 Jun 2026, with unfilled sell orders and a frozen price, signalling persistent selling pressure in a micro-cap stock with limited liquidity.

Read full news article

Valiant Laboratories Ltd Falls 5.46%: 2 Key Technical Events Shape the Week

2026-06-13 09:07:33

Key Events This Week

8 Jun: Stock opens at Rs.74.79, gains 1.30% despite Sensex decline

9 Jun: Sharp drop of 3.92% amid sector divergence

10 Jun: Hits lower circuit at Rs.69.18 amid heavy selling pressure

11 Jun: Continues decline, closing at Rs.67.18 (-4.03%)

12 Jun: Rebounds 3.90% with Golden Cross technical signal

Week Open

Rs.73.83

...

Read full news article

Golden Cross Forms in Valiant Laboratories Ltd — Mixed Technical Signals and Micro-Cap Caveats

2026-06-12 18:10:58

The 50-day moving average has crossed above the 200-day for Valiant Laboratories Ltd, signalling a golden cross on 12 Jun 2026. Yet, the broader technical picture is conflicted, with weekly and monthly indicators sending mixed messages, and the stock’s micro-cap status adding a layer of caution to interpreting this signal.

Read full news article

Valiant Laboratories Ltd is Rated Sell

2026-06-12 10:10:57

Valiant Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 8 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 June 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.

Read full news article

Valiant Laboratories Ltd Locks at Lower Circuit With 4.88% Loss — Sellers Queue, No Buyers in Sight

2026-06-10 12:00:11

At Rs 69.27, Valiant Laboratories Ltd found itself locked at its lower circuit limit of 5% on 10 Jun 2026, with persistent selling pressure overwhelming demand and leaving unfilled supply on the exchange floor.

Read full news article

Valiant Laboratories Ltd is Rated Sell

2026-06-01 10:10:51

Valiant Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

Valiant Laboratories Ltd Falls 0.75%: 3 Key Factors Driving the Week’s Volatility

2026-05-23 11:01:01

Key Events This Week

18 May: Quality grade upgrade signals mixed fundamentals

19 May: Valuation shifts indicate heightened price risk

21 May: Downgrade to Strong Sell amid mixed financial and technical signals

22 May: Week closes at Rs.78.19 (-0.75%)

Read full news article

Valiant Laboratories Downgraded to Strong Sell Amid Mixed Financial and Technical Signals

2026-05-21 08:28:13

Valiant Laboratories Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 20 May 2026, reflecting a complex interplay of improved quarterly financials but deteriorating quality and valuation metrics, alongside mixed technical indicators. Despite a positive financial trend in the latest quarter, concerns over long-term fundamentals and expensive valuation have weighed heavily on investor sentiment.

Read full news article

Valiant Laboratories Ltd Valuation Shifts Signal Heightened Price Risk

2026-05-19 08:02:54

Valiant Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation metrics shift markedly, moving from an already expensive rating to very expensive territory. Despite a recent downgrade in its Mojo Grade from Strong Sell to Sell, the stock has delivered mixed returns compared to the broader Sensex, prompting investors to reassess its price attractiveness amid challenging fundamentals and peer comparisons.